Health Impact and Cost-Effectiveness of Brief Tobacco Counseling in a US Birth Cohort of 4,000,000: Clinical Preventive Service Priorities Estimates
| Effect | Youth Counseling vs No Youth Counseling | Adult Counseling vs No Adult Counseling |
|---|---|---|
| Change in years lived as smokers, No. | −4,971,393 | −8,458,331 |
| Change in adult smoking prevalence (weighted by cohort size at each age), % | −2.0 | −3.8 |
| Change in years lived as former smokers, No. | −8,140,126 | 9,502,722 |
| Change in smoking-attributable cancers, No. | −9,925 | −14,679 |
| Change in smoking-attributable CVD hospitalizations, No. | −99,138 | −176,045 |
| Change in smoking-attributable respiratory disease hospitalizations, No. | −126,270 | −179,701 |
| Change in smoking-attributable fatalities, No. | −42,686 | −69,901 |
| Clinical preventable burden: change in QALYs saved, undiscounted, No. | 756,601 | 1,044,392 |
| Change in counseling and cessation medication costs, discounted, $ millions | 914 | 427 |
| Change in smoking-attributable medical costs, discounted, $ millions | −1,814 | −2,746 |
| Change in total costs, discounted, $ millions | −900 | −2,319 |
| Cost-effectiveness: discounted net costs per person, $/person | −225 | −580 |
CVD = cardiovascular disease; QALYs = quality-adjusted life years.